Walleye Trading Advisors »

Arrivent Biopharma shares owned by Walleye Trading Advisors

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Walleye Trading Advisors from 13F filings

Historical chart of Walleye Trading Advisors investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Walleye Trading Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Walleye Trading Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $447k 25k 17.86

More positions owned by Walleye Trading Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Tesla Motors Call Option (TSLA)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Select Sector Spdr Tr Financial Call Option (XLF)
Advanced Micro Devices Call Option (AMD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Netflix Call Option (NFLX)

View all positions for Walleye Trading Advisors

Top funds holding Arrivent Biopharma

Hillhouse Capital Advisors
OrbiMed Advisors
FMR
Octagon Capital Advisors
Suvretta Capital Management
Sofinnova Ventures
Novo A/S
General Catalyst Group Management
Sc China Holding
BlackRock
Vanguard Group
Cormorant Asset Management
Perceptive Advisors
Geode Capital Management
State Street Corporation

View all funds holding Arrivent Biopharma